Here’s a proposal I can live with:

A key U.S. Democrat made a renewed call on Monday for giving regulators the power to ban advertisements to consumers when a new medicine first reaches the market and risks are not fully known.

Rep. Henry Waxman listed the idea as one of many he would like to pursue as chairman of the House of Representatives Energy and Commerce Committee after a new Congress convenes in January and starts to tackle a range of health-care issues.

‘It is in these first few years of a drug’s life that drug companies often aggressively market their products and engage in direct-to-consumer advertising. This increases the number of consumers exposed to safety risks of new products long before those risks are truly understood,’ Waxman said at a conference sponsored by The Prescription Project, a group critical of industry marketing.

Here’s a good editorial from the medical community on why ads for prescription ads should be re-banned.